#Investors:
Novartis delivered a solid second quarter, returning to sales growth driven by continued momentum from priority brands.
We remain on track to deliver our full-year guidance and mid-term outlook.*
Press release: novartis.social/6013v4CD7
Webcast:
An innovative medicines company working to reimagine medicine. See our community guidelines: go.novartis.social/4bqbjuA
- On Tuesday, July 21, Novartis will announce its Q2 2026 results. Register to listen here: novartis.social/6017v2Nsl #NovartisNews $NVS $NOVN #NVSQ226
- #Investors: Novartis delivered strong growth in priority brands and recent launches during Q1 2026, while US generic erosion weighed on results as expected. We remain on track to deliver our full year guidance. Press release: go.novartis.social/4cCsrje IR Webcast:

